AsemconnectVietnam - Besides the positive Q1/2026 profit results, Hau Giang Pharmaceutical Joint Stock Company (DHG – HOSE) has just announced the schedule for the first dividend payment of 2025 at a rate of 50% in cash.

Specifically, on May 12th, the Company will finalize the list of shareholders to pay the first dividend for 2025. Accordingly, shareholders owning 1 share will receive VND5,000, with the payment expected on May 28th.
Notably, at the recent 2026 Annual General Meeting, Hau Giang Pharmaceutical approved a cash dividend of 100% of par value. DHG's management further emphasized that the company will maintain a stable dividend policy to pay shareholders, while investing moderately at VND300-400 billion per year and not making large investments in new factories in the near future.
Regarding business operations, according to the newly released Q1/2026 financial report, Hau Giang Pharmaceutical recorded net revenue of VND1,198 billion, a slight increase compared to the same period last year; pre-tax and after-tax profits reached VND347.3 billion and VND315.7 billion respectively, both showing growth of over 18%.
Explaining the double-digit profit growth, Hau Giang Pharmaceutical stated that, in addition to the slight increase in net revenue, the cost of goods sold decreased by 4.6%, to VND598 billion, thus, gross profit increased by 5.8% to VND600.2 billion.
In addition, the company significantly reduced expenses, such as financial expenses decreasing by 43.4% to VND12 billion, and selling expenses decreasing by 8.1% to VND185.5 billion.
In 2026, the company has set a conservative plan with a target of over VND5,530 billion in net revenue and VND1,007 billion in pre-tax profit. Thus, by the end of the first quarter, DHG had achieved 21.66% of its revenue target and 34.5% of its profit target for the year.
N.Nga
Source: VITIC/Tinnhanhchungkhoan